Two structurally unrelated pharmacological inhibitors that block HXA3 synthesis, used at concentrations thought to specifically inhibit 12-LOX(11, 27, 42), each significantly decreased PLY-induced PMN migration or in the lung after intratracheal instillation
Two structurally unrelated pharmacological inhibitors that block HXA3 synthesis, used at concentrations thought to specifically inhibit 12-LOX(11, 27, 42), each significantly decreased PLY-induced PMN migration or in the lung after intratracheal instillation. approximately 900,000 instances of pneumococcal pneumonia yearly, having a mortality rate of 5-7%, making the disease both a significant health and monetary burden(3, […]
Recent Comments